Bon Natural Life Signs Agreement With Tigerbone Group To Partner Across Traditional Chinese Medicine Products, Life Sciences Research, Nutritional Functional Foods
Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agreement (the "Agreement") with Tigerbone Group Limited ("Tigerbone Group"). As part of this strategic initiative, the parties also announced plans to establish the "BON Cooperation and Development Committee," which will serve as a central platform to advance collaboration in traditional Chinese medicine and life sciences through resource sharing and complementary strengths.
Pursuant to the Agreement, and based on principles of equality, voluntariness, resource sharing, complementary advantages, and mutual benefit, BON and Tigerbone Group will collaborate across traditional Chinese medicine products, life sciences research, and nutritional functional foods. Each party will retain its independent intellectual property rights and scientific research achievements, while jointly developing new products, technologies, and solutions to drive innovation and long-term value creation.
文章来源:富途牛牛
Bon Natural Life与Tigerbone Group签署协议,将在中成药产品、生命科学研究、营养功能食品领域展开合作。
推荐新闻
-
2026-01-16
多家权威媒体报道:聚焦生物制造与AI融合“健康中国与生物制造产业发展”座谈会在京举行
1月13日下午,“健康中国与生物制造产业发展”座谈会在新华社国家金融信息大厦举办。本次会议由新华网上市公司研究院与国声智...
